Skip to main content
. 2023 Mar 22;1(1):100002. doi: 10.1016/j.chstcc.2023.100002

Table 3.

Echocardiographic Assessments in Critically Ill Patients With COVID-19 Over Time (N = 110)a

Variable Day 1 (N = 110) Day 3 (n = 109) Day 8 (n = 102) P Value
LV systolic dysfunction, %b 42.2 (38 of 90) 45.1 (32 of 71) 36.2 (21 of 58) .416
LVEF, % 62 (52-69) 62 (56-67) 65 (58-73) < .001
LV longitudinal strain, % 16.0 (13.7-19.1) 16.0 (12.3-20.1) 18.2 (14.8-20.0) .085
RV dysfunction, %b 64.2 (52 of 81) 68.7 (46 of 67) 67.4 (31 of 46) .820
RV fractional area change, % 38.8 (32.8-47.5) 40.3 (32.9-45.8) 42.7 (36.6-49.1) .368
RV free-wall strain, % 19.2 (12.3-24.9) 18.3 (12.0-23.1) 20.8 (14.0-26.4) .327
Tricuspid annulus systolic plane excursion 2.0 (1.7-2.3) 2.0 (1.7-2.2) 2.0 (1.6-2.2) .264
RV to LV ratio 0.90 (0.78-0.97) 0.89 (0.75-1.03) 0.90 (0.81-1.06) .038
IVC collapsibility index 0.21 (0.12-0.51) 0.32 (0.11-0.57) 0.44 (0.18-0.65) .167
Presence of DVT on ultrasound, % 2.1 2.4 3.1 .999

Data are presented as median (interquartile range), unless otherwise indicated. IVC = inferior vena cava; LV = left ventricle; LVEF = left ventricular ejection fraction; RV = right ventricle.

a

Tests of significance are unadjusted for multiple comparisons. Strain is converted to absolute value.

b

Proportion of patients with right ventricular and with left ventricular dysfunction are reported, followed by the number of abnormal measurements among patients with interpretable function.